- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04856163
The Impact of Telelactation Services on Breastfeeding Outcomes
April 17, 2024 updated by: RAND
The Impact of Telelactation Services on Breastfeeding Outcomes: Digital Tele-MILC Trial
This project will assess the impact of a novel breastfeeding support intervention ("telelactation"), delivered via video calls on personal devices including mobile phones and tablets.
The goal of this intervention is to increase access to International Board Certified Lactation Consultants to improve, and reduce disparities in, breastfeeding rates.
By implementing a digital randomized controlled trial that recruits participants through a popular pregnancy tracker mobile phone application, this mixed methods study will recruit a national sample of 1800-2400 individuals (depending on rate of attrition) during their third trimester of pregnancy to 1) provide evidence on the effectiveness of a widely available, yet understudied, service and 2) leverage technology to promote one of the most widely recommended health behaviors to improve children's health and to reduce disparities in key maternal and child health outcomes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study is a pragmatic, parallel design randomized controlled trial that will generate evidence on the impact of telelactation on breastfeeding duration and exclusivity and explore differences in effectiveness by race/ethnicity.
The study is mixed methods, and uses a sequential explanatory design in which qualitative interviews are used to explain and contextualize findings from the quantitative outcomes analysis.
We will recruit primiparous, pregnant individuals age > 18 who intend to breastfeed and live in states most underserved by IBCLCs.
Recruitment will occur via Ovia, a pregnancy tracker mobile phone application (app) used by one million pregnant individuals in the U.S. annually.
Participants will be randomized to: 1) on-demand telelactation video calls on personal devices or 2) ebook on infant care/usual care.
Breastfeeding outcomes will be captured via surveys and interviews and compared across racial and ethnic groups.
This study will track participants for eight months (including six months postpartum), generating 1) quantitative data on the impact of telelactation and differences in effectiveness across racial and ethnic minority groups; and 2) rich qualitative data on the experiences of different subgroups of parents with the intervention, including barriers to use, satisfaction, and strengths and limitations of this delivery model.
Study Type
Interventional
Enrollment (Actual)
2109
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Virginia
-
Arlington, Virginia, United States, 22202
- RAND Corporation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- ≥ 18 years of age
- pregnant with first child
- intend to attempt breastfeeding
- residing in a state underserved by IBCLCs
Exclusion Criteria:
- non-singleton pregnancy
- advised by healthcare provider not to breastfeed for a medical reason (e.g., HIV+ status, chemotherapy planned)
- in police custody or incarcerated
- infant to be separated from birthing parent (e.g., given up for adoption, military deployment)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Telelactation support
Participants in the experimental group will receive unlimited, free telelactation visits with lactation consultants (IBCLCs) as demanded up to 24 weeks post-partum.
Services will be available through mobile phone app.
|
Participants will get unlimited access (through 24 weeks postpartum) to video calls with lactation consultants who are available 24/7.
Participants can use the service as demanded.
|
No Intervention: ebook
Participants in the control arm will receive care as usual.
They will also receive a ebook with content on infant care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Breastfeeding duration 1
Time Frame: 6 months postpartum
|
Any breastfeeding (yes/no) at 6 months
|
6 months postpartum
|
Breastfeeding duration 2
Time Frame: 6 months post-partum
|
Time to cessation of breastfeeding in months (as measured by reported age of infant when completely stopped receiving breastmilk)
|
6 months post-partum
|
Breastfeeding exclusivity
Time Frame: 6 months postpartum
|
No formula use in the prior 24 hours (yes/no) at 6 months
|
6 months postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Breastfeeding satisfaction
Time Frame: 6 months postpartum
|
Breastfeeding satisfaction (self-reported via questionnaire at 6 months postpartum).
Score on five-item maternal/infant breastfeeding satisfaction scale (which is a subscale of the H&H lactation scale).
|
6 months postpartum
|
Experiences with telelactation
Time Frame: 8 weeks postpartum
|
Qualitative data from semi-structured interviews on experiences with telelactation
|
8 weeks postpartum
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 8, 2021
Primary Completion (Actual)
September 30, 2023
Study Completion (Actual)
December 31, 2023
Study Registration Dates
First Submitted
April 19, 2021
First Submitted That Met QC Criteria
April 19, 2021
First Posted (Actual)
April 23, 2021
Study Record Updates
Last Update Posted (Actual)
April 19, 2024
Last Update Submitted That Met QC Criteria
April 17, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- R01NR018837 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Data resulting from the proposed research will be shared with external researchers who request access beginning one year after the project ends.
Results will be available to other researchers, public health workers, healthcare professionals, and community leaders who are interested in exploring approaches to improving breastfeeding rates following a brief application process.
Constraints imposed by human research subjects protection regulations (e.g., HIPAA Protected Health Information) and RAND's IRB will be recognized as allowed by NIH.
External researchers interested in investigator data, survey instruments, and other research methodology and procedures will obtain this information through collaborative agreements (e.g., data use agreements) with the principal investigator and co-investigators, as required by NIH's data sharing policy.
IPD Sharing Time Frame
2025-2028
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breastfeeding
-
Marmara UniversityNot yet recruitingBreastfeeding | Breastfeeding Support
-
University of CopenhagenDanish Committee for Health Education; Nordea-fonden; Det Obelske Familiefond; 21...Active, not recruiting
-
Halic UniversityCompletedBreastfeeding | Breastfeeding, ExclusiveTurkey
-
University of Ontario Institute of TechnologyDurham Region Health DepartmentUnknown
-
University of California, DavisUniversity of California, San Francisco; Public Hospital Roatan, HondurasCompletedBreastfeeding | Breastfeeding, ExclusiveHonduras
-
Ahi Evran University Education and Research HospitalThe Scientific and Technological Research Council of TurkeyCompletedBreastfeeding | Breastfeeding, Exclusive | Kangaroo Mother CareTurkey
-
University of SaskatchewanNot yet recruitingBreastfeeding | Breastfeeding, Exclusive | Breast Milk Collection
-
University of Mississippi Medical CenterActive, not recruitingBreastfeeding | Breastfeeding, ExclusiveUnited States
-
Celal Bayar UniversityManisa Celal Bayar UniversityCompletedBreastfeeding | Breastfeeding, ExclusiveTurkey
-
Benten Technologies, Inc.National Institute on Minority Health and Health Disparities (NIMHD); George... and other collaboratorsEnrolling by invitationBreastfeeding | Exclusive BreastfeedingUnited States
Clinical Trials on Telelactation support
-
RANDUniversity of PittsburghCompletedBreastfeedingUnited States
-
University of PittsburghPenn State UniversityCompleted
-
Kaiser PermanenteNational Heart, Lung, and Blood Institute (NHLBI); OCHIN, Inc.CompletedCardiovascular Disease | Diabetes MellitusUnited States
-
University of California, Los AngelesAll India Institute of Medical Sciences, New Delhi; University of California... and other collaboratorsCompleted
-
Health DialogHighmark Blue Cross Blue Shield; Health Net CaliforniaCompletedUterine Diseases | Arthritis | Spinal Diseases | Chronic Disease | Preventive Health ServicesUnited States
-
University of CalgaryHeart and Stroke Foundation of Canada; Canadian Council of Cardiovascular NursesCompletedCardiovascular DiseaseCanada
-
University of CalgaryNot yet recruiting
-
Istanbul University - Cerrahpasa (IUC)Not yet recruitingHigh School 11th Grade Students | Absence of Any Language, Hearing, Mental or Psychological Disability | Turkish Speaking and Understanding | Having a PUKI Index Above 5ı | Absence of Any Chronic Disease | Obtaining Permission From Parents and StudentsTurkey
-
University of CalgaryAlberta Health services; University of Alberta; Covenant HealthCompletedStrategy for Uptake of Processes for Recognizing and Responding to Acute Kidney Injury (SUPPORT AKI)Acute Kidney InjuryCanada